The HEAL Initiative offers this grant to accelerate implementing effective non-opioid interventions for chronic pain in rural populations. This grant supports pragmatic, implementation, or hybrid trials. Its purpose is to improve pain management, reduce inappropriate opioid use, and inform policymakers and providers. Awards include a milestone-driven planning phase (UG3, 1-2 years), potentially transitioning to an implementation phase (UH3, up to 4 years). Applicants must partner with rural healthcare systems and community organizations, ensuring interventions are integrated effectively into underserved areas.
Opportunity ID: 343556
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-NR-23-001 |
| Funding Opportunity Title: | HEAL Initiative: Prevention and Management of Chronic Pain in Rural Populations (UG3/UH3, Clinical Trials Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.121 — Oral Diseases and Disorders Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 16, 2022 |
| Last Updated Date: | Sep 16, 2022 |
| Original Closing Date for Applications: | Nov 21, 2022 |
| Current Closing Date for Applications: | Nov 21, 2022 |
| Archive Date: | Dec 27, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | County governments Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Public and State controlled institutions of higher education Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses State governments For profit organizations other than small businesses Public housing authorities/Indian housing authorities |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) encourages UG3/UH3 phased cooperative research applications to accelerate implementation of effective non-opioid interventions for chronic pain management in rural and remote populations. Projects include pragmatic, implementation, or hybrid effectiveness-implementation trials to improve pain management and reduce the use of inappropriate opioid medications. Awards made under this FOA will initially support a milestone-driven, planning phase (UG3) of 1 to 2 years, with possible transition to an implementation phase (UH3) of up to 4 years duration (5 years total for the two phases). UG3 projects that have met the scientific milestone and feasibility requirements may transition to the UH3 phase. The UG3/UH3 application must be submitted as a single application, following the instructions described in this FOA. The overall goal of this initiative is to support the “real world” implementation of effective interventions to manage pain in rural and remote areas. Results from the trials supported by this funding opportunity announcement (FOA) should inform policy makers, payers, community stakeholders, as well as health care providers and patients in the primary care, emergency department, hospital, home health, or dental setting. This FOA requires that the investigators partner with one or more rural healthcare system(s) to plan and implement the intervention. During the planning phase, investigators must develop an additional one or more community-based partnership(s). Studies may propose to integrate multi-component, bundled, or multi-level interventions that have demonstrated efficacy. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-NR-23-001.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00276838 | Oct 22, 2022 | Nov 21, 2022 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278469 | Nov 15, 2022 | Nov 21, 2022 | View |
Package 1
Mandatory forms
343556 RR_SF424_5_0-5.0.pdf
343556 PHS398_CoverPageSupplement_5_0-5.0.pdf
343556 RR_OtherProjectInfo_1_4-1.4.pdf
343556 PerformanceSite_4_0-4.0.pdf
343556 RR_KeyPersonExpanded_4_0-4.0.pdf
343556 RR_Budget_3_0-3.0.pdf
343556 PHS398_ResearchPlan_4_0-4.0.pdf
343556 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
343556 RR_SubawardBudget30_3_0-3.0.pdf
343556 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
343556 RR_SF424_5_0-5.0.pdf
343556 PHS398_CoverPageSupplement_5_0-5.0.pdf
343556 RR_OtherProjectInfo_1_4-1.4.pdf
343556 PerformanceSite_4_0-4.0.pdf
343556 RR_KeyPersonExpanded_4_0-4.0.pdf
343556 RR_Budget_3_0-3.0.pdf
343556 PHS398_ResearchPlan_5_0-5.0.pdf
343556 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
343556 RR_SubawardBudget30_3_0-3.0.pdf
343556 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
